Ad26.COV2.S boosts antibody and T-cell responses following BNT162b2 vaccination

Emerg Microbes Infect. 2021 Dec;10(1):2220-2222. doi: 10.1080/22221751.2021.2006581.
No abstract available

Publication types

  • Letter

MeSH terms

  • Ad26COVS1 / administration & dosage*
  • Antibodies, Neutralizing / immunology
  • Antibodies, Viral / immunology
  • BNT162 Vaccine / administration & dosage*
  • COVID-19 / immunology
  • COVID-19 / prevention & control*
  • COVID-19 / virology
  • Humans
  • SARS-CoV-2 / genetics
  • SARS-CoV-2 / immunology
  • T-Lymphocytes / immunology*
  • Vaccination

Substances

  • Ad26COVS1
  • Antibodies, Neutralizing
  • Antibodies, Viral
  • BNT162 Vaccine